<DOC>
	<DOCNO>NCT02808806</DOCNO>
	<brief_summary>The purpose ARTEMIS trial investigate real-time feedback caregiver reduces time patient 's first medical contact start intravenous thrombolysis and/or intraarterial thrombectomy patient acute ischemic stroke .</brief_summary>
	<brief_title>A Reduction Time With Electronic Monitoring In Stroke Trial</brief_title>
	<detailed_description>Background For clinical benefit intravenous thrombolysis ( IVT ) intra-arterial thrombectomy ( IAT ) time crucial factor . Reducing time stroke onset treatment therefore major goal acute stroke care . The delay first moment Emergency Medical Services ( EMS ) dispatch office alarm initiation treatment ( IVT and/or IAT ) , i.e . 'total system delay ' ( TSD ) , depend greatly logistics collaboration various caregiver trajectory . A promising method improve workflow thereby aim reduce TSD provide real-time visual feedback caregiver . Methods The A Reduction Time Electronic Monitoring In Stroke ( ARTEMIS ) trial multiregional , multicenter , prospective randomize open end-point trial investigate intervention real-time visual feedback caregiver reduce TSD IVT/IAT . The intervention compromise real-time visual feedback caregiver actual treatment delay individual patient . Randomization intervention do alternate calendar period ( i.e . without real-time visual feedback ) . Study procedures Patients receive unique wristband emit low-voltage Bluetooth signal ( activate open EMS personnel time ambulance dispatch ) , automatically pick handhelds ambulance pre-mounted in-hospital tablet en route treatment IVT and/or IAT . In calendar week intervention , handhelds tablet provide caregiver real-time visual feedback actual treatment time delay patient transfer . Furthermore , colour cod feedback ( green red ) provide easy-view visualization whether pre-set median time delay location exceed . TSD IVT/IAT start moment dispatch office issue ambulance patient potentially eligible IVT/IAT . TSD end moment IVT/IAT give . For TSD IVT moment bolus intravenous alteplase administer , TSD IAT puncture groin moment reperfusion establish . These endpoint register use real-life push button CT-ward/neuro-care unit catheterization room , respectively . After treatment , first 24-48 hour admission hospital , inform consent ask patient legal representative collection anonymous clinical data Electronic Patient Recording ( EPR ) assess clinical outcome modify Rankin Score ( mRS ) three month observer blind treatment allocation . Statistical Analysis For primary analysis secondary analysis involve endpoint time interval , difference time delay calendar week without intervention calculate correspond 95 % confidence interval . The investigator perform subgroup analysis IAT patient with- without prior IVT . Subsequently investigator use linear regression analysis adjust EMS region location treatment expect affect TSD IVT/IAT . In additional regression analysis investigator ass effect time TSD whether effect group dependent . The total number time ambulance drive patient suspect acute stroke use calculate proportion patient discharge diagnosis stroke total number IVT/IAT treat patient use calculate IVT/IAT rate treatment control week . Exploratory analysis perform relate TSD clinical outcome group . Sample size estimate Sample size calculation base hypothesis least 20-minute reduction TSD IAT least 10 minute reduction TSD IVT . The investigator think reduction feasible base data `` MR CLEAN '' ( n=500 ) standard deviation TSD IAT 40 minute , TSD IVT standard deviation 35 minutes.3 Moreover , experience investigator reduce in-hospital delay IVT experience recent Dutch study manage reduce TSD acute myocardial infarction ( AMI ) patient 40 minute ( 180 140 minute ) real-time visual feedback ( manuscript preparation ) support view goal realistic . Also , run-in phase investigator collect additional data treatment delay adjust sample size calculation appropriate . For investigator use ( unpublished ) data `` MR CLEAN '' trial . In `` MR CLEAN '' trial ( n=500 ) , mean TSD IAT 233 patient 256 minute ( SD : 40 minute ) . To detect 20-minute difference p-value 0.05 , power 0.8 investigator need 63 patient arm . To increase power , investigator aim include 75 patient IAT arm . For co-primary outcome , TSD IVT , `` MR CLEAN '' trial mean TSD IVT 90 minute ( SD : 35 minute ) . To detect 10-minute difference p-value 0.05 , power 0.8 investigator need 193 IVT treat patient arm . In clinical practice approximately 9 % patient dispatch office send ambulance end treat IVT . Of patient approximately 30 % eligible IAT include primary endpoint . Therefore investigator expect inclusion 150 IAT patient end treated IAT wristband unpack ambulance personnel approximately 5000 time . Of , approximately 500 patient end treated IVT ; subsequently , population around 150 patient treated IAT .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<criteria>patient older 18 year consider potentially eligible IVT/IAT dispatch office , follow regional EMS ' standard stroke algorithm . age &lt; 18 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>stroke</keyword>
	<keyword>cerebral infarction</keyword>
	<keyword>brain infarction</keyword>
	<keyword>ischemic stroke</keyword>
	<keyword>treatment</keyword>
	<keyword>intravenous thrombolysis</keyword>
	<keyword>intraarterial thrombectomy</keyword>
	<keyword>delay</keyword>
	<keyword>total system delay</keyword>
	<keyword>pre-hospital delay</keyword>
	<keyword>in-hospital delay</keyword>
	<keyword>feedback</keyword>
	<keyword>real-time feedback</keyword>
	<keyword>visual feedback</keyword>
</DOC>